Research Article

Dexamethasone-Activated MSCs Release MVs for Stimulating Osteogenic Response

Figure 1

Characterization of MSC-MVs (n-MVs or DXM-MVs). MSCs were activated by treatment with 10−8, 10−7, and 10−6 M DXM. (a) Size distribution and concentration of MSC-MVs detected by NTA analysis. (b) Typical morphology of MSC-MVs investigated by a transmission electron microscope. (c) Flow cytometric analysis showing the expression of MSC-specific marker CD90 in MSC-MVs.
(a)
(b)
(c)